Let's all raise our glasses for a toast to the outperformers of this bull market.

Ok, now let's get to work finding stocks setting up that will likely catch the next wave of rotating capital flows.

Today's trade is in a name that is slowly becoming a fixture at just about every eating establishment near me, and likely you too.

Here's a one-year chart of Toast Inc, $TOST:

By itself, this is a chart I Iike to buy. But Strazza shares a longer-term chart in the video above that displays the opportunity better.

$TOST is just now showing signs of breaking out of a multi-year base.

But when there is overhead supply to contend with, the breakouts aren't always as clean as we'd like them to be. So we will take advantage of options premiums at out-of-the-money strikes to help keep our cost of participation limited.

Here's the Play:

I like buying a $TOST March 30/40 Bull Call Spread for approximately $2.50 net debit. This means I'll be long the 30 calls and short an equal amount of the 40 calls. The most I can lose is the premium I pay today. And that could be a real possibility if we get a...

Technology stocks have been underperforming for the last three months.

However, when I dive beneath the surface looking for relative strength, software stocks catch my attention.

Here you have the Software ETF $IGV on the cusp of breaking out of a massive base.

IGV soared higher, tacking on 2.14% today as it pierced through the upper bounds of this range.

If and when we get some upside follow-through, the breakout will be valid and the path of least resistance will be higher. We think this happens in the coming days and weeks.

Under this scenario, we should anticipate upside resolutions from individual software names. A lot of them look very similar to IGV right now.

Palantir Technologies $PLTR is one of my favorites setups in the space.

How could it not be? It's been the best one.

The notorious government contractor is just breaking out above its IPO high from 2021.

It has a lot of room to run.

In today’s Daily Digest, we’ll review the following:

1. New position in KRE (regional banks).
2. No adjustments are needed today.
3. No exits since the last report.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

From the Desk of Steve Strazza @Sstrazza

When investing in the stock market, we always want to approach it as "a market of stocks."

Regardless of the environment, there are always stocks showing leadership and trending higher.

We may have to look harder to identify them depending on current market conditions. But there are always stocks that are going up.

The same can be said for weak stocks. Regardless of the environment, there are always stocks that are going down, too. 

We already have multiple scans focusing on stocks making all-time highs, such as Hall of Famers, Minor Leaguers, and the 2 to 100 Club.

We filter these universes for stocks that are exhibiting the best momentum and relative strength characteristics. 

Setups that will turn into 5x, 10x, and 20x winners during earnings season are forming right now.

You're seeing that normal directionless consolidation that develops before explosive moves.

Our proprietary Breakout Multiplier System is specially designed to identify these stocks before volatility begins to expand.

The time to enter is now.

...

The most significant insider activity on today's list comes via a 13D filing by Mubadala Investment Company.

The sovereign wealth fund, which manages a portfolio for the government of Abu Dhabi, reported an initial stake of 9.50% in Equinox Gold Corp $EQX.

The fund's top holdings include GlobalFoundries and Evotec SE.

It’s not uncommon for insiders to buy stocks when they’re still in the accumulation or base-building phase. We see them buy downtrends and beaten-up names all the time as well. 

What we don’t see as much is insiders stepping in and reporting a brand-new stake just as a fresh trend reversal is shaping up.

That’s what is happening here with EQX and Mubadala’s $230 million investment.

Here’s The Hot Corner, with data from October 7, 2024:

JC has been giving a special mastermind class on Technical Analysis, and last week he invited me on to discuss momentum thrusts and crossovers. You can watch it here.

We dove into a variety of topics, covering initiation vs exhaustion, thrust clusters, and even a conversation on the difference between MACD and PPO.

One of the points I hoped to drive home in this presentation was around how to know when a momentum thrust is significant. 

For me, momentum thrusts and breadth thrusts are exactly the same in this way. When they are notable, they are hard to miss. They come in spurts and clusters.

What do I mean by this?

Let’s use China as an example because I think we are witnessing a historic initiation phase right now.

A few weeks ago, Chinese stocks had their second-best day in history. 

Then, they had...

A couple of weeks ago, we talked about Silver futures attempting to emerge from a multi-year accumulation pattern and potentially retesting the former all-time high.

Last week,  Silver made a new multi-decade high in absolute terms and broke a multi-year downtrend line relative to Gold. 

And if the 47th element is about to blast off, we should look closer at the Junior Silver Miners.

But first, check out this chart of the Silver/Gold ratio:

Below is the 4th ASC Mastermind Lab Course. These are special videos that will be made available throughout the duration of the 12-week course featuring conversations with professionals from across Wall Street discussing topics in their expertise. 

The theme of ASC Mastermind Week 2 is momentum trading, and why it works. So naturally it made sense for me to talk to All Star Charts Director of Research Steve Strazza. Steve uses momentum as much in his day-to-day as I do. 

The main concept Steve wanted to hammer home is momentum thrusts, what they are, when they happen, the different types with examples, and how to analyze them. 

Enjoy this Mastermind Lab Course on momentum.

Earnings season is closing in. And the election is right behind it. Surely land mines will be discovered all over the place. There is risk.

So any directional bets I place over the coming weeks will be of a defined-risk nature.

But, where there is risk, there is opportunity. We'll get paid when we're right, perhaps handsomely so.

That is why it is worth wading into the rising rivers here to take some shots while keeping our downsides in check.

Today, I joined my friend Patrick on Chart Request Live, discussing all the ticker symbols from the chat.

Click here to watch the replay.

One major topic we discussed at the end of the show was crypto and some equity vehicles to gain exposure to it.

One that stood out was MicroStrategy $MSTR, which continues to show impressive relative strength.

As you can see, MSTR is consolidating above its prior cycle peak as it flirts with new all-time highs.

Meanwhile, Bitcoin continues...

In today’s Daily Digest, we’ll review the following:

1. New position in XLP (consumer staples).
2. No adjustments are needed today.
3. Exited SMH position.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

From the Desk of Steve Strazza @Sstrazza

Welcome to The Minor Leaguers.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

Nowadays, to make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.

And it doesn't have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.

The same price and liquidity filters are applied. Then, as always, we sort by proximity to new highs in order to focus...

The last time the yield curve inverted, they promised us a recession, maybe even a market crash if we're lucky!

Instead all we got was a historic bull market, including back to back years of 20%+ returns in the S&P500. 

You see, this is what happened AFTER the yield curve inverted.

And why is this such a big deal? 

There's this really hilarious function in the way humans think. A large population of economists and wall street sell side analysts get very sad when the yield of one bond pays more than the yield of another.

It's this really weird thing in the markets that gets these folks very afraid, and so they want their customers to be afraid too. 

And if these economists and sell side analysts do their jobs right, as they have for many years, they're loyal following of sheep will be sure to sell their stocks and run to cash just before a historic bull market.

And that, of course, is exactly what happened over the past couple of years, as investors piled into more money market funds than any other time in history, only for that to be one of the worst possible decisions any investor could have made at any point since...

The most notable insider activity on today's list comes via a Form 4 filing by Cartesian Therapeutics Inc $RNAC director Timothy A. Springer.

Springer reported a $4.2 million purchase of RNAC shares.

Neuberger Berman Group LLC filed a 13G for CNX Resources Corporation $CNX, revealing an initial stake of 5.03%.

Here’s The Hot Corner, with data from October 4, 2024:

This is the tape to begin thinking about taking trade setups.

As such, here are three potential meme coin trades.

It appears this seven month bear market is reaching its concluding stages.

There is an increasing number of bullish developments that point to a Bitcoin breakout.

I think there is going to be tremendous opportunity to make money in the altcoins in the coming quarters.

From the Desk of Steve Strazza @Sstrazza

The market keeps squeezing short sellers out of their biotech positions and rewarding bulls with big breakouts. 

Knowing this, our strategy is simple. We want to keep buying the best-looking and most heavily-shorted biotech stocks.

Today, we're covering one that has rallied nearly 200% since late last year. Despite this extreme upside momentum, the stock still has a massive short interest.

With the stock resolving a multi-year accumulation pattern, we think this short squeeze has plenty of room to run. To get back to the all-time highs from just a few years ago, it would require about a 10x.

We're looking for something much smaller and quicker for now, but you never know!

Let's talk about how we're trading our latest Freshly Squeezed setup.